Development of CCR5 ligands—This strategy aims to develop molecules that will bind to CCR5 and prevent the interaction between CCR5 and the gp120 HIV protein thereby aborting HIV entry mediated by fusion and infection. This evidence concerns the gene CCR5 and infection.